CANIXIN DHPPI LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR DOGS Ireland - English - HPRA (Health Products Regulatory Authority)

canixin dhppi lyophilisate and solvent for suspension for injection for dogs

virbac s.a. - canine distemper virus (lederle strain), canine parvovirus (cpv 780916 strain), canine adenovirus type 2 (manhattan strain), canine parainfluenza (manhattan strain) - lyophilisate and solvent for suspension for injection - per cent - canine distemper virus vaccine + canine adenovirus vaccine + canine parvovirus vaccine + canine para - canine - immunological - live vaccine

CANIXIN DHPPi lyophilisate and solvent for suspension for injection for dogs Ireland - English - HPRA (Health Products Regulatory Authority)

canixin dhppi lyophilisate and solvent for suspension for injection for dogs

virbac s.a. - canine distemper virus (lederle strain); canine parvovirus (cpv 780916 strain); canine adenovirus type 2 (manhattan strain); canine parainfluenza (manhattan strain) - lyophilisate and solvent for suspension for injection - . cell culture infective dose 50 - canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus - dogs - immunological - live vaccine

CANIXIN DHPPI/L LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION FOR DOGS Ireland - English - HPRA (Health Products Regulatory Authority)

canixin dhppi/l lyophilisate and suspension for suspension for injection for dogs

virbac s.a. - canine distemper virus (lederle strain), canine adenovirus type 2 (manhattan strain), canine parvovirus (cpv 780916 strain), canine parainfluenza (manhattan strain), buffered isotonic solution, l.canicola, l.icterohaemorrhagiae - suspension for injection - unknown - live canine distemper virus vaccine + live canine adenovirus vaccine + live canine parainfluenza vi - canine - immunological - live vaccine

Hipradog 7 Formulation: Each mL of reconstituted vaccine (dose) contains: Canine Parvovirus (C-780916 Strain)......>10^6 TCID50 Canine Distemper Virus (Lederle Strain)...........>10^4 TCID50 Canine Adenovirus Type 2 (Manhattan Strain)............>10^4 TCID50 Canine Parainfluenza Virus (CPIV) (Penn 103/70 Strain)....... ......>10^5 TCID50 Leptospira interrogans ser. Icterohaemorrhagiae..........>10^9 microorganisms Leptospira interrogans ser. Canicola.................. >10^9 microorganisms TCID-Tissue Culture Infective Dose Freeze Dried Powder for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

hipradog 7 formulation: each ml of reconstituted vaccine (dose) contains: canine parvovirus (c-780916 strain)......>10^6 tcid50 canine distemper virus (lederle strain)...........>10^4 tcid50 canine adenovirus type 2 (manhattan strain)............>10^4 tcid50 canine parainfluenza virus (cpiv) (penn 103/70 strain)....... ......>10^5 tcid50 leptospira interrogans ser. icterohaemorrhagiae..........>10^9 microorganisms leptospira interrogans ser. canicola.................. >10^9 microorganisms tcid-tissue culture infective dose freeze dried powder for injection (sc)

hipra philippines, inc.; distributor: hipra philippines, inc. - live attenuated canine parvovirus (cpv) , canine distemper virus (cdv) , canine adenovirus type 2 (cav 2) , canine parainfluenza (cpiv) vaccine , leptospira interrogans ser. icterohaemorrhagiae , l. interrogans ser. canicola vaccine (vet.) - freeze dried powder for injection (sc) - formulation: each ml of reconstituted vaccine (dose) contains: canine parvovirus (c-780916 strain)......>10^6 tcid50 canine distemper virus (lederle strain)...........>10^4 tcid50 canine adenovirus type 2 (manhattan strain)............>10^4 tcid50 canine parainfluenza virus (cpiv) (penn 103/70 strain)....... ......>10^5 tcid50 leptospira interrogans ser. icterohaemorrhagiae..........>10^9 microorganisms leptospira interrogans ser. canicola.................. >10^9 microorganisms tcid-tissue culture infective dose

Recombitek C6 Each 1.0 mL dose of vaccine contains the following through expiration: Active Ingredients: Canine Distemper, Canarypox Vector .............................................. ≥106.4 TCID50 Canine Adenovirus Type 2 ............................................................. ≥104.3 TCID50 Canine Parainfluenza .................................................................... ≥103.9 TCID50 Canine Parvovirus ........................................................................ ≥103.3 FAID50 Leptospira canicola ....................................................... ≥40 nephelometric units Leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *TCID-Tissue Culture Infective Dose **FAID. Fluorescent Antibody Infective Dose ***NTU- Nephelometric Units Lyophilized Powder for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

recombitek c6 each 1.0 ml dose of vaccine contains the following through expiration: active ingredients: canine distemper, canarypox vector .............................................. ≥106.4 tcid50 canine adenovirus type 2 ............................................................. ≥104.3 tcid50 canine parainfluenza .................................................................... ≥103.9 tcid50 canine parvovirus ........................................................................ ≥103.3 faid50 leptospira canicola ....................................................... ≥40 nephelometric units leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *tcid-tissue culture infective dose **faid. fluorescent antibody infective dose ***ntu- nephelometric units lyophilized powder for injection (im/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) vaccine , inactivated leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae vaccine (vet.) - lyophilized powder for injection (im/sc) - each 1.0 ml dose of vaccine contains the following through expiration: active ingredients: canine distemper, canarypox vector .............................................. ≥106.4 tcid50 canine adenovirus type 2 ............................................................. ≥104.3 tcid50 canine parainfluenza .................................................................... ≥103.9 tcid50 canine parvovirus ........................................................................ ≥103.3 faid50 leptospira canicola ....................................................... ≥40 nephelometric units leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *tcid-tissue culture infective dose **faid. fluorescent antibody infective dose ***ntu- nephelometric units

Megavac-6 Formulation: Each 1 mL (dose) contains: Canine Distemper Virus ........>10^3 TCID50 Canine Adenovirus Type 2 .............................. > 10^3 TCID50 Canine Parvovirus .................................. >128 HA Canine Adenovirus Type 1 ................ > 81 SN50/ 0.05 mL Leptospira interrogans ser. Canicola Leptospira interrogans ser. Icterohaemorrhagiae TCID - Tissue Culture Infective Dose HA - Hemagglutination Assay SN-Serum Neutralization Freeze-Dried Pellet for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

megavac-6 formulation: each 1 ml (dose) contains: canine distemper virus ........>10^3 tcid50 canine adenovirus type 2 .............................. > 10^3 tcid50 canine parvovirus .................................. >128 ha canine adenovirus type 1 ................ > 81 sn50/ 0.05 ml leptospira interrogans ser. canicola leptospira interrogans ser. icterohaemorrhagiae tcid - tissue culture infective dose ha - hemagglutination assay sn-serum neutralization freeze-dried pellet for injection (im/sc)

unahco, inc.; distributor: unahco, inc. - live canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , inactivated canine adenovirus type 1 (cav-1) , leptospira interrogans ser. canicola , l. interrogans ser. ictero haemorrhagiae vaccine (vet.) - freeze-dried pellet for injection (im/sc) - formulation: each 1 ml (dose) contains: canine distemper virus ........>10^3 tcid50 canine adenovirus type 2 .............................. > 10^3 tcid50 canine parvovirus .................................. >128 ha canine adenovirus type 1 ................ > 81 sn50/ 0.05 ml leptospira interrogans ser. canicola leptospira interrogans ser. icterohaemorrhagiae tcid - tissue culture infective dose ha - hemagglutination assay sn-serum neutralization

COMPANION C3 TRIVALENT LIVING VACCINE FOR DOGS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

companion c3 trivalent living vaccine for dogs

intervet australia pty limited - canine distemper virus - living; canine adenovirus type 2 - live (infectious hepatitis); canine parvovirus - live - misc. vaccines or anti sera - canine distemper virus - living vaccine-viral active 0.0 p; canine adenovirus type 2 - live (infectious hepatitis) vaccine-viral active 0.0 p; canine parvovirus - live vaccine-viral active 0.0 p - immunotherapy - dog | bitch | castrate | puppy - canine distemper | canine parvovirus | hepatitis :- infectious | vaccine | canine adenovirus type 1 | canine adenovirus type 2 | equine rotavirus | infectious canine hepatitis | parvovirus

CANVAC 4 + CCI COMBINATION VACCINE PACK Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

canvac 4 + cci combination vaccine pack

zoetis australia pty ltd - bordetella bronchiseptica (inactivated cell free extract; canine distemper virus - living; canine parainfluenza virus; canine adenovirus type 2 live (cav ii); canine parvo virus type 2 - parenteral liquid/solution/suspension - bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.0 qs dose; canine distemper virus - living vaccine-viral active 0.0 qs dose; canine parainfluenza virus vaccine-viral active 0.0 qs dose; canine adenovirus type 2 live (cav ii) vaccine-viral active 0.0 qs dose; canine parvo virus type 2 vaccine-viral active 0.0 qs dose - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine distemper | canine parvovirus | hepatitis :- infectious | parainfluenza virus type 2 (infections) | canine adenovirus type 1 | canine adenovirus type 2 | canine cough syndrome | infections caused by parainflu | infectious canine hepatitis | infectious tracheobronchitis | parvovirus

CANINE ADENOVIRUS TYPE 2, STRAIN MANHATTAN Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

canine adenovirus type 2, strain manhattan

zoetis australia pty ltd - canine adenovirus type 2, strain manhattan - unknown - canine adenovirus type 2, strain manhattan vaccine-viral active 0.0 - active constituent

CANINE ADENOVIRUS, TYPE 2 (CAV2) STRAIN MANHATTAN LPV3 Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

canine adenovirus, type 2 (cav2) strain manhattan lpv3

intervet australia pty limited - canine adenovirus type 2 - unknown - canine adenovirus type 2 vaccine-virus active 0.0 - active constituent